T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.01B |
| 2 |
Broadcom
AVGO
|
+$1.49B |
| 3 |
GE Vernova
GEV
|
+$1.19B |
| 4 |
International Paper
IP
|
+$1.05B |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$952M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.31B |
| 2 |
Constellation Energy
CEG
|
+$1.94B |
| 3 |
Qualcomm
QCOM
|
+$1.74B |
| 4 |
NVIDIA
NVDA
|
+$1.71B |
| 5 |
Salesforce
CRM
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.98% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Leslie's
LESL
$6.55M
| $419K | ﹤0.01% |
4,992
+643
| +15% | +$62.5K |
|
2252
TETRA Technologies
TTI
$1.25B
| $419K | ﹤0.01% |
120,838
+18,116
| +18% | +$72.3K |
|
|
BHR
2253
Braemar Hotels & Resorts
BHR
$139M
| $418K | ﹤0.01% |
163,571
+4,417
| +3% | +$11.6K |
|
2254
Global Industrial
GIC
$1.48B
| $417K | ﹤0.01% |
13,290
+434
| +3% | +$15.9K |
|
2255
Ocugen
OCGN
$451M
| $417K | ﹤0.01% |
268,820
+81,720
| +44% | +$127K |
|
2256
Edgewise Therapeutics
EWTX
$4.71B
| $416K | ﹤0.01% |
23,086
+6,662
| +41% | +$116K |
|
2257
Shutterstock
SSTK
$210M
| $416K | ﹤0.01% |
10,746
+893
| +9% | +$36.3K |
|
|
ZIMV
2258
DELISTED
ZimVie
ZIMV
| $415K | ﹤0.01% |
22,719
+1,188
| +6% | +$19.5K |
|
|
CTO
2259
CTO Realty Growth
CTO
$825M
| $414K | ﹤0.01% |
23,711
+600
| +3% | +$10.4K |
|
|
CWEN.A
2260
DELISTED
Clearway Energy Class A
CWEN.A
| $414K | ﹤0.01% |
18,267
+6,017
| +49% | +$140K |
|
2261
Invesco Mortgage Capital
IVR
$807M
| $413K | ﹤0.01% |
43,987
+1,446
| +3% | +$13K |
|
2262
Western New England Bancorp
WNEB
$282M
| $411K | ﹤0.01% |
59,650
| – | – |
|
2263
Alignment Healthcare
ALHC
$2.94B
| $410K | ﹤0.01% |
52,368
+7,519
| +17% | +$49.1K |
|
|
CHCT
2264
Community Healthcare Trust
CHCT
$436M
| $408K | ﹤0.01% |
17,440
+754
| +5% | +$18.3K |
|
2265
Camping World
CWH
$664M
| $408K | ﹤0.01% |
22,839
+3,279
| +17% | +$69.1K |
|
2266
Argan
AGX
$8.04B
| $406K | ﹤0.01% |
5,542
-114
| -2% | -$7.47K |
|
|
INN
2267
Summit Hotel Properties
INN
$654M
| $406K | ﹤0.01% |
67,638
+1,857
| +3% | +$11.4K |
|
2268
Theravance Biopharma
TBPH
$880M
| $406K | ﹤0.01% |
47,780
-1,695
| -3% | -$15.3K |
|
2269
Forward Air
FWRD
$656M
| $403K | ﹤0.01% |
21,137
+533
| +3% | +$11K |
|
2270
Simulations Plus
SLP
$371M
| $403K | ﹤0.01% |
8,273
-1,775
| -18% | -$83.7K |
|
2271
Orion
OEC
$363M
| $402K | ﹤0.01% |
18,309
+2,478
| +16% | +$59.7K |
|
|
FINV
2272
FinVolution Group
FINV
$1.03B
| $401K | ﹤0.01% |
+84,034
| New | +$411K |
|
|
NVEI
2273
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $401K | ﹤0.01% |
+12,356
| New | +$398K |
|
2274
Ichor Holdings
ICHR
$2.63B
| $400K | ﹤0.01% |
10,353
+2,176
| +27% | +$82.9K |
|
2275
James River Group Holdings
JRVR
$194M
| $400K | ﹤0.01% |
51,681
+13,692
| +36% | +$113K |
|
Similar funds
T. Rowe Price Associates's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
- T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
- T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
- T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
- T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
- T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.
Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.